Back to Top

Expert Opinion on Investigational Drugs (EOID)

Publisher :

Taylor & Francis

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • the needs of scientists
  • managers
  • decision-makers
  • +4

e-ISSN :

1744-7658

Issue Frequency :

Monthly

Impact Factor :

4.9

p-ISSN :

1354-3784

Est. Year :

1992

Mobile :

4402080520500

DOI :

YES

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

GOOGLE SCHOLAR

Email :

enquiries@taylorandfrancis.com

Journal Descriptions

Expert Opinion on Investigational Drugs [ISSN 1354-3784]; [e-ISSN 1744-7658] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on drugs in preclinical and early-stage clinical development, providing expert opinion on the scope for future development. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Opinion on Investigational Drugs address the needs of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. The Editors welcome: Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies. Drug Evaluations reviewing the clinical and pharmacological data on a particular drug. Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials. Please note that we do not consider case report or case series articles.


Expert Opinion on Investigational Drugs (EOID) is :

International, Peer-Reviewed, Open Access, Refereed, the needs of scientists, managers, decision-makers, pharmaceutical industry, clinical development, providing expert opinion, the scope for future development , Online or Print, Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 1354-3784, E-ISSN - 1744-7658, Established in - 1992, Impact Factor - 4.9

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile